DreaMed

DreaMed

Hospitals and Health Care

Petah Tikva, Mercaz 6,700 followers

AI that transforms diabetes data into expert level treatment recommendations

About us

Founded in 2014, our company pioneered the first artificial pancreas technology. Since then, DreaMed has dedicated itself to developing decision-support tools in the diabetes management field. We are the world's first and only company to receive FDA clearance for a decision support system that utilizes data from CGM/SMBG (continuous glucose monitoring/self-monitoring of blood glucose) and insulin pumps. Our founders are all physicians and engineers. Our products are developed based on real insights from the clinical practice of diabetes specialists, physicians, and clinical researchers from the top diabetes centers worldwide. We prioritize privacy, security, quality, and regulatory compliance, operating under a stringent quality management system and adhering to ISO 27001, GDPR, and HIPAA standards. Additionally, our product FDA-cleared.

Website
http://www.dreamed.ai
Industry
Hospitals and Health Care
Company size
11-50 employees
Headquarters
Petah Tikva, Mercaz
Type
Privately Held
Founded
2014
Specialties
Medical Device, Diabetes, Software, Diabetes Management, decision support, remote care, FDA, and Artificial intelligence

Locations

  • Primary

    14 Kaplan St

    Institute for Endocrinology and Diabetes, Suite 20. POB 3271

    Petah Tikva, Mercaz 4920235, IL

    Get directions
  • 1650 W End Blvd

    St. Louis Park, Minnesota 55416, US

    Get directions

Employees at DreaMed

Updates

Similar pages

Funding

DreaMed 4 total rounds

Last Round

Series unknown

US$ 3.0M

See more info on crunchbase